Literature DB >> 11826042

Synergistic enhancement of glutamate-mediated responses by serotonin and forskolin in adult mouse spinal dorsal horn neurons.

Guo-Du Wang1, Min Zhuo.   

Abstract

Glutamate is the major excitatory amino acid neurotransmitter in the CNS, including the neocortex, hippocampus, and spinal cord. Normal synaptic transmission is mainly mediated by glutamate AMPA and/or kainate receptors. Glutamate N-methyl-D-aspartate (NMDA) receptors are normally inactive and only activated when a sufficient postsynaptic depolarization is induced by the activity. Here we show that in sensory synapses of adult mouse, some synaptic responses (26.3% of a total of 38 experiments) between primary afferent fibers and dorsal horn neurons are almost completely mediated by NMDA receptors. Dorsal root stimulation did not elicit any detectable AMPA/kainate receptor-mediated responses in these synapses. Unlike young spinal cord, serotonin alone did not produce any long-lasting synaptic enhancement in adult spinal dorsal horn neurons. However, co-application of the adenylyl cyclase activator forskolin and serotonin (5-HT) produced long-lasting enhancement, including the recruitment of functional AMPA receptor-mediated responses. Calcium-sensitive, calmodulin-regulated adenylyl cyclases (AC1, AC8) are required for the enhancement. Furthermore the thresholds for generating action potential responses were decreased, and, in many cases, co-application of forskolin and 5-HT led to the generation of action potentials by previously subthreshold stimulation of primary afferent fibers in the presence of the NMDA receptor blocker 2-amino-5-phosphonovaleric acid. Our results suggest that pure NMDA synapses exist on sensory neurons in adult spinal cord and that they may contribute to functional sensory transmission. The synergistic recruitment of functional AMPA responses by 5-HT and forskolin provides a new cellular mechanism for glutamatergic synapses in mammalian spinal cord.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11826042     DOI: 10.1152/jn.00423.2001

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  12 in total

1.  Human safety study of a selective neuronal adenylate cyclase 1 inhibitor NB001 which relieves the neuropathic pain and blocks ACC in adult mice.

Authors:  Weicong Wang; Qi-Yu Chen; Pengpeng Zhao; Jingbo Zhong; Yan Wang; Xiaorong Li; Min Zhuo; Xia Chen
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

2.  Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology.

Authors:  L Ciranna
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

3.  Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex.

Authors:  Hui Xu; Long-Jun Wu; Hansen Wang; Xuehan Zhang; Kunjumon I Vadakkan; Susan S Kim; Hendrik W Steenland; Min Zhuo
Journal:  J Neurosci       Date:  2008-07-16       Impact factor: 6.167

4.  Endogenous analgesia, dependence, and latent pain sensitization.

Authors:  Bradley K Taylor; Gregory Corder
Journal:  Curr Top Behav Neurosci       Date:  2014

5.  An NPY Y1 receptor antagonist unmasks latent sensitization and reveals the contribution of protein kinase A and Epac to chronic inflammatory pain.

Authors:  Weisi Fu; Tyler S Nelson; Diogo F Santos; Suzanne Doolen; Javier J P Gutierrez; Na Ye; Jia Zhou; Bradley K Taylor
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

6.  Genetic reduction of chronic muscle pain in mice lacking calcium/calmodulin-stimulated adenylyl cyclases.

Authors:  Kunjumon I Vadakkan; Hansen Wang; Shanelle W Ko; Evelyn Zastepa; Michele J Petrovic; Kathleen A Sluka; Min Zhuo
Journal:  Mol Pain       Date:  2006-02-17       Impact factor: 3.395

7.  Optimization of a Pyrimidinone Series for Selective Inhibition of Ca2+/Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic Pain.

Authors:  Jason A Scott; Monica Soto-Velasquez; Michael P Hayes; Justin E LaVigne; Heath R Miller; Jatinder Kaur; Karin F K Ejendal; Val J Watts; Daniel P Flaherty
Journal:  J Med Chem       Date:  2022-03-10       Impact factor: 8.039

Review 8.  Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain.

Authors:  Xu-Hui Li; Qi-Yu Chen; Min Zhuo
Journal:  Neurotherapeutics       Date:  2020-09-15       Impact factor: 7.620

Review 9.  The development of descending serotonergic modulation of the spinal nociceptive network: a life span perspective.

Authors:  Anne R de Kort; Elbert A J Joosten; Jacob Patijn; Dick Tibboel; Nynke J van den Hoogen
Journal:  Pediatr Res       Date:  2021-07-13       Impact factor: 3.953

Review 10.  Neuronal mechanism for neuropathic pain.

Authors:  Min Zhuo
Journal:  Mol Pain       Date:  2007-06-06       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.